BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/22/2022 8:57:44 AM | Browse: 257 | Download: 318
 |
Received |
|
2021-12-17 22:22 |
|
Peer-Review Started |
|
2021-12-17 22:24 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-01-25 08:50 |
|
Revised |
|
2022-02-08 01:11 |
|
Second Decision |
|
2022-03-07 06:06 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-03-17 04:17 |
|
Articles in Press |
|
2022-03-17 04:17 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2022-03-17 07:49 |
|
Publish the Manuscript Online |
|
2022-03-22 08:57 |
| ISSN |
1949-8462 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Cardiac & Cardiovascular Systems |
| Manuscript Type |
Retrospective Study |
| Article Title |
Risk profiles and outcomes of patients receiving antibacterial cardiovascular implantable electronic device envelopes: A retrospective analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
David A Woodard, Grace Kim and Kent R Nilsson |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Aziyo Biologics, Inc. |
|
|
| Corresponding Author |
David A Woodard, MD, Doctor, Department of Cardiology, Piedmont Heart Institute, Piedmont Athens Regional Medical Center
242 King Ave Suite 210, Athens, GA 30606, United States. davidwoodard92464@gmail.com |
| Key Words |
Cardiovascular implantable electronic device envelope; Defibrillator; Extracellular matrix; Implantable cardioverter-defibrillator; Infection; Pacemaker |
| Core Tip |
This retrospective study was performed to determine risk profiles and clinical outcomes of patients who underwent cardiovascular implantable electronic device (CIED) procedures with a biologic or non-biologic antibacterial envelope, or no envelope. A total of 248 patient records were reviewed containing 89 biologic, 102 non-biologic, and 57 no envelope patients. Pre-procedurally, patients who received any envelope (biologic or non-biologic) were at higher infection risk than patients who received no envelope. Biologic envelopes tended to be used more often in higher risk patients than non-biologic envelopes. The rate of CIED pocket infection was low and equivalent between the two envelopes. |
| Publish Date |
2022-03-22 08:57 |
| Citation |
Woodard DA, Kim G, Nilsson KR. Risk profiles and outcomes of patients receiving antibacterial cardiovascular implantable electronic device envelopes: A retrospective analysis. World J Cardiol 2022; 14(3): 177-186 |
| URL |
https://www.wjgnet.com/1949-8462/full/v14/i3/177.htm |
| DOI |
https://dx.doi.org/10.4330/wjc.v14.i3.177 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
